Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study.
Saved in:
| Title: | Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study. |
|---|---|
| Authors: | Bruel T; Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France.; Vaccine Research Institute, Créteil, France., Pinaud L; Emerging Diseases Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France., Tondeur L; Emerging Diseases Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France., Planas D; Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France.; Vaccine Research Institute, Créteil, France., Staropoli I; Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France., Porrot F; Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France., Guivel-Benhassine F; Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France., Attia M; Molecular Genetics of RNA Viruses Unit, Institut Pasteur, Université Paris Cité, Paris, France., Pelleau S; Infectious Disease Epidemiology and Analytics Unit, Institut Pasteur, Université Paris Cité, Paris, France., Woudenberg T; Infectious Disease Epidemiology and Analytics Unit, Institut Pasteur, Université Paris Cité, Paris, France., Duru C; Hôpital de Crépy-en-Valois, Crépy-en-Valois, France., Koffi AD; Hôpital de Crépy-en-Valois, Crépy-en-Valois, France., Castelain S; Laboratoire de virologie, CHU Amiens, AGIR UR4294, UPJV, Amiens, France., Fernandes-Pellerin S; Centre for Translational Science, Institut Pasteur, Paris, France., Jolly N; Centre for Translational Science, Institut Pasteur, Paris, France., De Facci LP; Clinical Investigation and access to bioresources (ICAReB) platform, Centre for Translational Science, Institut Pasteur, Paris, France., Roux E; Clinical Investigation and access to bioresources (ICAReB) platform, Centre for Translational Science, Institut Pasteur, Paris, France., Ungeheuer MN; Clinical Investigation and access to bioresources (ICAReB) platform, Centre for Translational Science, Institut Pasteur, Paris, France., Van Der Werf S; Molecular Genetics of RNA Viruses Unit, Institut Pasteur, Université Paris Cité, Paris, France., White M; Infectious Disease Epidemiology and Analytics Unit, Institut Pasteur, Université Paris Cité, Paris, France., Schwartz O; Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France.; Vaccine Research Institute, Créteil, France., Fontanet A; Emerging Diseases Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France.; Conservatoire National des Arts et Métiers, PACRI Unit, Paris, France. |
| Source: | EClinicalMedicine [EClinicalMedicine] 2022 Jul 22; Vol. 51, pp. 101576. Date of Electronic Publication: 2022 Jul 22 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
